Assessment the effect of chamomilla on early menopausal complications in menopausal women

INTERVENTION: Control group: 4 caps of placebo, daily for 12 weeks Intervention 1: Intervention group: 4 100mg‐caps of chamomilla, daily for 12 weeks. Intervention 2: Control group: 4 caps of placebo, daily for 12 weeks. Intervention group: 4 100mg‐caps of chamomilla, daily for 12 weeks Placebo Treatment ‐ Drugs CONDITION: Menopausal and female climacteric states menopause complication. ; Menopausal and female climacteric states PRIMARY OUTCOME: Reduce of menopause complications. Timepoint: 4 & 8 &12 weeks later. Method of measurement: Scorecard Scale. SECONDARY OUTCOME: Enjoyed life. Timepoint: 4&8&12weeks later. Method of measurement: Scorecard Scale. INCLUSION CRITERIA: nclusion criteria: A total score of more than 15 (means that the women needs a hormone replacement therapy), normal pelvic ultrasound or normal pelvic exam , and FSH>40 or two years of lmp. Exclusion criteria: Women who received hormone therapy during the last 6 months, on a diet or herbal treatment; hypercholesterolemia, thyroid disorders, hypertension, diabetes, family history of heart disease, cigarette smoking, serious illnesses (malignancy)